Although a role of EBV in autoimmunity is biologically plausible and evidence of altered immune responses to EBV is abundant in several autoimmune diseases, inference on causality requires the determination that disease risk is higher in individuals infected with EBV than in those uninfected and that in the latter it increases following EBV infection. This determination has so far been possible only for multiple sclerosis (MS) and, to some extent, for systemic lupus erythematosus (SLE), whereas evidence is either lacking or not supportive for other autoimmune conditions. In this chapter, we present the main epidemiological findings that justify the conclusion that EBV is a component cause of MS and SLE and possible mechanisms underlying these effects.
CITATION STYLE
Ascherio, A., & Munger, K. L. (2015). EBV and autoimmunity. In Epstein Barr Virus (Vol. 1, pp. 365–385). Springer International Publishing. https://doi.org/10.1007/978-3-319-22822-8_15
Mendeley helps you to discover research relevant for your work.